Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis (SHaRCS)

This study has been completed.
Information provided by (Responsible Party):
NanoBio Corporation Identifier:
First received: March 22, 2011
Last updated: May 15, 2013
Last verified: May 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2012
  Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: May 15, 2013